Our Team

Overview

We have assembled a strong management team with a broad network of connections and corporate relationships across the pharmaceutical industry. We are confident that we will be able to use our individual experiences as well as our networks to achieve success. Together, we will formulate an all-encompassing plan for growth, one that accounts for both organic expansion and expansion via mergers and acquisitions. In the end, we will attempt to transform our target company into a widely respected industry leader by leveraging the benefits of becoming a public company, including access to finance and equity for expansion. At the same time, we will endeavor to generate excellent returns for our shareholders.

Executive Team

https://dmaacorp2.com/wp-content/uploads/2025/09/lynnfinal20251.png

Lynn Stockwell

CEO & Executive Chair
https://dmaacorp2.com/wp-content/uploads/2025/02/glenn-worman-copy-1-e1738783690333.jpg

Glenn Worman

Chief Financial Officer

Nominees for our Board of Directors

https://dmaacorp2.com/wp-content/uploads/2025/02/catherine-255-e1738785552457.jpg

Dr. Catherine Do

Director
https://dmaacorp2.com/wp-content/uploads/2025/02/Sridhar-Prasad-FINAL.png

Dr. G. Sridhar Prasad

Director
https://dmaacorp2.com/wp-content/uploads/2025/02/4-2.png

Myron W. Shulgan, KC

Director

Advisory Team

https://dmaacorp2.com/wp-content/uploads/2025/09/charles-temp.png

Charles C. Conaway

https://dmaacorp2.com/wp-content/uploads/2025/02/Paul-Mastronardi.jpg

Paul J. Mastronardi

https://dmaacorp2.com/wp-content/uploads/2025/02/Untitled-Project-2.jpg

Edward A. Robinson